Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(22 sites)

Australia

St Vincent's Health Sydney, Sydney, New South Wales

Prince of Wales Hospital, Sydney, New South Wales

Blacktown Hospital, Sydney, New South Wales

Royal Prince Alfred Hospital, Sydney, New South Wales

Wollongong Hospital, Illawarra Shoalhaven Health, Wollongong, New South Wales